Silpa Gampala

711 total citations
12 papers, 408 citations indexed

About

Silpa Gampala is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Silpa Gampala has authored 12 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Silpa Gampala's work include DNA Repair Mechanisms (3 papers), Single-cell and spatial transcriptomics (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Silpa Gampala is often cited by papers focused on DNA Repair Mechanisms (3 papers), Single-cell and spatial transcriptomics (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Silpa Gampala collaborates with scholars based in United States, Taiwan and Germany. Silpa Gampala's co-authors include Melissa L. Fishel, Mark R. Kelley, Jer‐Yen Yang, Chih‐Yu Chang, Chun–Ju Chang, Richard A. Messmann, Chi Zhang, Xiaoyu Lu, Yong Zang and Sha Cao and has published in prestigious journals such as Cell Metabolism, Cancer Research and Genome Research.

In The Last Decade

Silpa Gampala

11 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silpa Gampala United States 9 316 93 75 47 38 12 408
Yaqi Cheng China 9 230 0.7× 131 1.4× 50 0.7× 58 1.2× 30 0.8× 28 358
Valérie Vial France 8 205 0.6× 147 1.6× 68 0.9× 35 0.7× 16 0.4× 14 332
Yu Xiong China 10 235 0.7× 115 1.2× 60 0.8× 32 0.7× 30 0.8× 34 360
Lata Singh India 12 188 0.6× 68 0.7× 122 1.6× 106 2.3× 29 0.8× 63 455
Mariam Markouli Greece 12 286 0.9× 95 1.0× 104 1.4× 65 1.4× 37 1.0× 27 469
Peter Szaniszlo United States 10 189 0.6× 53 0.6× 54 0.7× 37 0.8× 36 0.9× 19 349
Edward J. Sanderlin United States 9 242 0.8× 82 0.9× 78 1.0× 58 1.2× 24 0.6× 11 380
Liwei Xiao China 5 244 0.8× 198 2.1× 88 1.2× 128 2.7× 33 0.9× 7 434
Sarbajeet Nagdas United States 8 288 0.9× 123 1.3× 146 1.9× 76 1.6× 34 0.9× 15 502

Countries citing papers authored by Silpa Gampala

Since Specialization
Citations

This map shows the geographic impact of Silpa Gampala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silpa Gampala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silpa Gampala more than expected).

Fields of papers citing papers by Silpa Gampala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silpa Gampala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silpa Gampala. The network helps show where Silpa Gampala may publish in the future.

Co-authorship network of co-authors of Silpa Gampala

This figure shows the co-authorship network connecting the top 25 collaborators of Silpa Gampala. A scholar is included among the top collaborators of Silpa Gampala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silpa Gampala. Silpa Gampala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Mijit, Mahmut, Silpa Gampala, Chi Zhang, et al.. (2023). Activation of the integrated stress response (ISR) pathways in response to Ref-1 inhibition in human pancreatic cancer and its tumor microenvironment. Frontiers in Medicine. 10. 1146115–1146115. 8 indexed citations
2.
3.
Mijit, Mahmut, Silpa Gampala, Christian Schneeweis, et al.. (2022). RelA Is an Essential Target for Enhancing Cellular Responses to the DNA Repair/Ref-1 Redox Signaling Protein and Restoring Perturbated Cellular Redox Homeostasis in Mouse PDAC Cells. Frontiers in Oncology. 12. 826617–826617. 8 indexed citations
4.
Yang, Yi, Silpa Gampala, Bumsoo Han, et al.. (2022). Abstract 2447: Unraveling the role of the fibrinolytic system in pancreatic cancer progression. Cancer Research. 82(12_Supplement). 2447–2447.
5.
Chang, Wennan, Xiaoyu Lu, Changlin Wan, et al.. (2021). A graph neural network model to estimate cell-wise metabolic flux using single-cell RNA-seq data. Genome Research. 31(10). 1867–1884. 121 indexed citations
6.
Mijit, Mahmut, et al.. (2021). APE1/Ref-1 – One Target with Multiple Indications: Emerging Aspects and New Directions. PubMed. 2(3). 151–161. 27 indexed citations
7.
Gampala, Silpa, Fenil Shah, Chi Zhang, et al.. (2021). Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours. British Journal of Cancer. 124(9). 1566–1580. 10 indexed citations
8.
Gampala, Silpa, Fenil Shah, Xiaoyu Lu, et al.. (2021). Ref-1 redox activity alters cancer cell metabolism in pancreatic cancer: exploiting this novel finding as a potential target. Journal of Experimental & Clinical Cancer Research. 40(1). 251–251. 27 indexed citations
9.
Gampala, Silpa & Jer‐Yen Yang. (2021). Hedgehog Pathway Inhibitors against Tumor Microenvironment. Cells. 10(11). 3135–3135. 27 indexed citations
10.
Gampala, Silpa, et al.. (2021). Activation of AMPK sensitizes medulloblastoma to Vismodegib and overcomes Vismodegib‐resistance. FASEB BioAdvances. 3(6). 459–469. 8 indexed citations
11.
Gampala, Silpa, et al.. (2020). The multifunctional APE1 DNA repair–redox signaling protein as a drug target in human disease. Drug Discovery Today. 26(1). 218–228. 76 indexed citations
12.
Wu, Meng‐Ju, Yu−Syuan Chen, Mee‐Ran Kim, et al.. (2018). Epithelial-Mesenchymal Transition Directs Stem Cell Polarity via Regulation of Mitofusin. Cell Metabolism. 29(4). 993–1002.e6. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026